Top Markets
Coin of the day
BioMark Diagnostics Inc. BioMark Diagnostics Inc.

BioMark Diagnostics Inc.

BUX
Rank in Stocks #26215
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Share Price
$0.37430781
Market Cap
$39.34M
Change (1 day)
-12.07%
Change (1 year)
48.36%
Country
CA
Trade BioMark Diagnostics Inc. (BUX)

Category

Operating Margin for BioMark Diagnostics Inc. (BUX)
Operating Margin as of 2026 TTM: 0.00%
According to BioMark Diagnostics Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for BioMark Diagnostics Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
17.69% -
US
20.42% -
US
0.00% -
CN
-10.70% -
US
21.50% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.